Vimta Labs Limited

BSE:524394 Stock Report

Market Cap: ₹22.1b

Vimta Labs Past Earnings Performance

Past criteria checks 3/6

Vimta Labs has been growing earnings at an average annual rate of 27.2%, while the Life Sciences industry saw earnings growing at 25.3% annually. Revenues have been growing at an average rate of 13.7% per year. Vimta Labs's return on equity is 14.4%, and it has net margins of 14.6%.

Key information

27.2%

Earnings growth rate

27.1%

EPS growth rate

Life Sciences Industry Growth11.2%
Revenue growth rate13.7%
Return on equity14.4%
Net Margin14.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Vimta Labs makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:524394 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,3764931,0750
30 Jun 243,1764111,0560
31 Mar 243,1934101,0580
31 Dec 233,2124131,0440
30 Sep 233,1694151,0190
30 Jun 233,2344839990
31 Mar 233,1904829800
31 Dec 223,1094739750
30 Sep 223,0094889370
30 Jun 222,9654538790
31 Mar 222,7874138340
31 Dec 212,6443727710
30 Sep 212,5573367380
30 Jun 212,3963147180
31 Mar 212,1102146650
31 Dec 201,9451376370
30 Sep 201,8731046350
30 Jun 201,694375940
31 Mar 201,811686530
31 Dec 191,9141366840
30 Sep 191,9061406730
30 Jun 192,0252006710
31 Mar 192,1302536650
31 Dec 182,1262366660
30 Sep 182,0712456460
30 Jun 181,9702186210
31 Mar 181,8361645950
31 Dec 171,6931345620
30 Sep 171,6021045480
30 Jun 171,552835340
31 Mar 171,5381065030
31 Dec 161,468944600
30 Sep 161,376744330
30 Jun 161,344793490
31 Mar 161,247643820
31 Dec 151,202634860
30 Sep 151,157594750
30 Jun 151,068453160
31 Mar 151,073513430
31 Dec 141,082524770
30 Sep 141,140854660
30 Jun 141,1951144550
31 Mar 141,1831324430

Quality Earnings: 524394 has high quality earnings.

Growing Profit Margin: 524394's current net profit margins (14.6%) are higher than last year (13.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 524394's earnings have grown significantly by 27.2% per year over the past 5 years.

Accelerating Growth: 524394's earnings growth over the past year (19%) is below its 5-year average (27.2% per year).

Earnings vs Industry: 524394 earnings growth over the past year (19%) did not outperform the Life Sciences industry 38.1%.

Return on Equity

High ROE: 524394's Return on Equity (14.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 19:02
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vimta Labs Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Vijay MadunalaFirstCall Research